Discover Top 10 Vaccine Manufacturers in Spain 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Spain has been experiencing significant growth in recent years, with a focus on vaccine manufacturing. In 2024, the global vaccine market size was estimated to be $52 billion, with Spain emerging as a key player in vaccine production. With advancements in technology and an increasing focus on healthcare, Spain is poised to become a major player in the global vaccine market by 2026.

Top 10 Vaccine Manufacturers in Spain 2026:

1. Pfizer Spain: With a production volume of 100 million doses per year, Pfizer Spain is a leading vaccine manufacturer in the country. The company is known for its innovative research and development in the field of vaccines.

2. Grifols: Grifols is a Spanish pharmaceutical company that specializes in plasma-derived products, including vaccines. With a market share of 15%, Grifols is a key player in the vaccine market in Spain.

3. GlaxoSmithKline (GSK) Spain: GSK Spain is a subsidiary of the global pharmaceutical giant, GSK. The company produces a wide range of vaccines, with a trade value of $500 million in exports annually.

4. Sanofi Pasteur Spain: Sanofi Pasteur is a leading vaccine manufacturer globally, with a presence in Spain. The company has a production volume of 80 million doses per year, contributing significantly to the vaccine market in Spain.

5. Novartis Spain: Novartis is a Swiss multinational pharmaceutical company with a strong presence in Spain. The company produces vaccines for a variety of diseases, with a market share of 10% in Spain.

6. Roche Spain: Roche is a global healthcare company with a focus on pharmaceuticals, including vaccines. With a trade value of $300 million in exports, Roche is a key player in the vaccine market in Spain.

7. AstraZeneca Spain: AstraZeneca is a British-Swedish multinational pharmaceutical company with a presence in Spain. The company produces vaccines for a range of diseases, contributing to the vaccine market in Spain.

8. Merck Spain: Merck is a leading global healthcare company with a presence in Spain. The company produces vaccines for various diseases, with a production volume of 70 million doses per year.

9. Johnson & Johnson Spain: Johnson & Johnson is a multinational healthcare company with a focus on pharmaceuticals, including vaccines. With a market share of 8% in Spain, Johnson & Johnson is a key player in the vaccine market.

10. Moderna Spain: Moderna is a US-based biotechnology company known for its mRNA vaccine technology. With a production volume of 60 million doses per year, Moderna is a key player in the vaccine market in Spain.

Insights:

The vaccine market in Spain is set to grow significantly by 2026, with a projected market size of $1 billion. The increasing focus on preventive healthcare and the development of new vaccines for emerging diseases will drive this growth. Additionally, collaborations between Spanish vaccine manufacturers and global pharmaceutical companies will further boost the vaccine market in Spain. With a strong infrastructure and a skilled workforce, Spain is well-positioned to become a major player in the global vaccine market in the coming years.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →